If you believe the fluid mosaic model of membrane structure, all the important jobs of the cell membrane, such as nutrient uptake, ion transport and transduction of hormonal signals, are attributable to membrane proteins rather than to the lipid bilayer in which they sit. But if all the membrane lipids do is to form a permeability barrier, you might expect them to have quite uniform structures. In fact, they are highly diverse, suggesting they have additional, more subtle roles in membrane function.
One of the most important and best understood roles of membrane lipids and/or their products is to function as intracellular second messengers, which convey the information encoded in extracellular messengers, such as hormones, neurotransmitters and growth factors, to produce an appropriate cellular response. More recently, lipids have been shown to regulate essential functions of membranes themselves, providing crucial, yet poorly understood, signals which control the flow of membrane traffic between the major organelles of eukaryotic cells.
Specialised signalling roles
The inositol-containing phospholipids are minor membrane constituents that have diverse chemical structures. They provide cells with an astonishing variety of signals whose functions we are only just beginning to understand in detail. Phosphatidylinositol 4,5-bisphosphate (PI(4,5)P 2 ) is one of the lynchpins of this network of putative signalling molecules. It is the major substrate for two groups of stimulusdependent enzymes. Enzymes of the phospholipase C family (PLCs) cleave PI(4,5)P 2 to generate two independent second messengers: diacylglycerol (DAG), which activates several species of protein kinase C, and inositol 1,4,5-trisphosphate (I(1,4,5)P 3 ), which releases Ca 2+ from intracellular stores. The second group of enzymes, type I PI 3-kinases, phosphorylate PI(4,5)P 2 to generate phosphatidylinositol 3,4,5-trisphosphate (PI(3,4,5)P 3 ) whose functions will be discussed later (see Figure 1) . PI 3-kinases and PLCs are found in all eukaryotic cells and their activities are regulated by a wide variety of hormones, neurotransmitters and growth factors.
In addition to its role as a precursor of signals, PI(4,5)P 2 seems to function as a distinct signal in its own right. For example, it can regulate actin polymerisation via its interaction with proteins such as profilin, gelsolin and vinculin; it is a necessary co-factor for another signal-generating enzyme, phospholipase D (discussed later); and its synthesis on the cytosolic leaflets of secretory vesicles seems to be required to confer secretory competence on these structures.
How can a single lipid have so many different roles? The answers are only just beginning to emerge but two important properties of PI(4,5)P 2 , and of the enzymes that regulate its level in cells, illustrate principles which are likely to be common themes of lipid signalling.
Location
One mechanism by which the functions of inositol phospholipids could remain distinct would be the spatial segregation of pools of different membrane lipids. The precursor phospholipid phosphatidylinositol (PI), can be targeted to distinct membrane compartments by a PI transfer protein. Because inositol phospholipids are likely to remain in the membrane in which they are synthesized, it should be possible for lipid kinases -which could be either cytosolic or specific to the Magazine R865
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The many different roles of phosphatidylinositol 4,5-bisphosphate (PI(4,5)P 2 ),which is a precursor of the signals PI(3,4,5)P 3 , DAG and I(1,4,5)P 3 , as well as functioning as a signal in its own right. The structure of PI(4,5)P 2 shows the typical inositol headgroup, which is linked by a phosphodiester phosphate group at the 1 position to the third carbon of the glycerol backbone. Stearic acid at the 1 position and arachidonic acid at the 2 position of glycerol provide the lipid components which anchor these inositol phospholipids within the cytosolic leaflets of cellular membranes. Phophate groups (P) are shown in green. relevant membrane compartment -to synthesize spatially segregated pools of PI(4,5)P 2 for particular purposes.
Several isoforms of PI and PIP kinases have been isolated and cloned, providing invaluable tools with which to test this attractive hypothesis. One thing we can say is that in many cells a majority of the PI(4,5)P 2 is located in the plasma membrane, where it is immediately available for hydrolysis by receptorstimulated PLCs. It also seems likely that PI 3-kinases will access the same, or at least an overlapping, pool of this lipid. Other functions of PI(4,5)P 2 , such as those illustrated in Figure 1 , must therefore involve relatively small pools of this lipid, probably located in other intracellular membranes.
Specific protein binding
The inositol phosphate headgroups of the inositol phospholipids are ideally suited to forming highaffinity, structure-dependent interactions with target proteins. For example I(1,4,5)P 3 , the soluble product of PLC activity, binds to its specific receptor in the endoplasmic reticulum with an affinity at least one-thousand-fold greater than those of closely related molecules such as I(1,3,4)P 3 .
An important breakthrough in understanding inositol-lipiddependent signalling mechanisms has been the discovery of small protein domains, known as pleckstrin homology (PH) domains, which have the characteristics required of receptors for PI(4,5)P 2 , PI(3,4,5)P 3 and PI(3,4)P 2 . These lipids bind to distinct subsets of the PH domains, which are present in a large number of functionally distinct proteins, many of which seem to have important roles in signalling. This binding interaction brings the receptor protein to the membrane in which its lipid ligand is located and may in addition directly regulate the protein's activity.
One of the best understood examples of this type of mechanism concerns the activation of protein kinase B (PKB), a central component of insulin-and growth-factorsignalling pathways. PKB and an upstream regulatory kinase, phosphoinositide-dependent protein kinase 1 (PDK1), both have PH domains that bind PI(3,4,5)P 3 with high affinity and specificity. This has at least two effects: it brings PKB and PDK1 together at the plasma membrane when PI(3,4,5)P 3 levels rise in response to, say, insulin, and it induces a conformational change in the structure of PKB that exposes a threonine residue which is then phosphorylated by PDK1 (Figure 2 ). This lipid-dependent co-localisation, allowing phosphorylation and activation, is a common mechanism for diverse PI(3,4,5)P 3 -mediated signalling pathways.
Another example of a specific phosphoinositide receptor is the EEA1 protein, which contains a cysteine-rich domain called a FYVE finger. This domain binds to PI3P, a lipid signal produced by distinct families of PI 3-kinases that only use PI as a substrate. Through this interaction, specific membrane sorting events such as vesicle docking and/or fusion, may be controlled by mechanisms that cause the local synthesis of PI3P. The use of a lipid -locked to the surface of the vesicle in which it was madeas a signal in membrane trafficking events is an elegant solution to the problem of fidelity in membrane dynamics.
The phospholipase paradox
As mentioned already, the hydrolysis of PI(4,5)P 2 by PLCs generates a lipid signal, DAG (Figure 1) , which activates several species of protein kinase C. DAG is then rapidly metabolised by DAG kinases to phosphatidate (PA). More recent studies have identified a second type of phospholipase, phospholipase D (PLD), which is activated by a wide variety of cell stimuli and catalyses hydrolysis of the membrane phospholipid phosphatidylcholine directly to PA; then PA phosphohydrolases convert this PA to DAG.
Despite the fact that they apparently generate the same overall products, several lines of evidence suggest that cellular responses which result from activation of PLD are functionally distinct from those that result from activation of PLCs. Moreover, both DAG and PA are critical intermediates in lipid biosynthetic pathways, so there must be a mechanism for segregating the housekeeping roles of these lipids from their evident signalling functions.
The solutions to these apparent paradoxes are likely to involve the general principles of location and structural specificity discussed already. For example, PLCs generate mainly DAG/PA with stearoyl arachidonoyl fatty acid tails, reflecting the fatty acid composition of the PI(4,5)P 2 from which they were derived. These lipids are then recycled back to resynthesize the signalling pool of PI, apparently without impinging upon de novo PI(3,4,5)P 3 -mediated localization and activation of PKB. Protein kinases PDK1 and PKB are co-localised through binding of their respective PH domains to PI(3,4,5)P 3 (which is formed when PI 3-kinase is activated). This binding induces a conformational change in PKB, which exposes a threonine residue that is phosphorylated by PDK1, which in turn activates PKB.
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PI 3-kinase PI(4,5)P 2 ATP ADP Current Biology Cytosol P P P P P P P P P PDK1 PKB phospholipid biosynthetic pathways. How this is achieved is one of the main unanswered questions in lipid signalling. By contrast, PLDs generate mainly PA species with saturated or mono-unsaturated fatty acid tails and there is emerging evidence that these products exert specific cellular responses, including triggering the formation of actin stress fibres, stimulation of exocytosis and regulation of vesicle formation. Whether they achieve these effects by binding to protein targets specific for these PA species, or through the biophysical effects resulting from hydrolysis of phosphatidylcholinewhich is a major structural component of membranes -is not yet clear.
The recent cloning of genes encoding eukaryotic PLDs has been an important breakthrough that promises to help solve some of the unanswered questions in this field. Two major isoforms, PLD1 and PLD2, have been identified to date in mammalian cells. PLD1 requires PI(4,5)P 2 as a co-factor and is confined to the perinuclear region of cells, whereas PLD2 is found mainly in the plasma membrane. This differential localization and their different regulatory properties suggest PLD1 and PLD2 have distinct cellular roles.
Sphingomyelin and cell death
Sphingomyelin is a membrane phospholipid that is derived from sphingosine (as opposed to glycerol, like the inositol phospholipids). There is a growing body of evidence that sphingomyelin can serve as a source of lipid second messengers, but this idea is still controversial and currently raises far more questions than it answers. The evidence includes the fact that many stimuli in a range of cell types cause the apparent hydrolysis of sphingomyelin, leading to detectable increases in the level of ceramide and sometimes also of a secondary product of ceramide metabolism, sphingosine 1-phosphate. It is not known which sphingomyelinase(s) is/are responsible for the accumulation of ceramide, nor even whether the stimulated reaction involves a sphingomyelinase or some other route of ceramide synthesis and/or metabolism.
More convincing than the above are the numerous observations that the addition of ceramide or sphingosine 1-phosphate to cells induces well-characterized cellular responses consistent with these molecules having signalling roles. Even here, unresolved questions abound: for example, sphingosine 1-phosphate has been claimed to act intracellularly by releasing Ca 2+ from intracellular stores in a similar response to that effected by I(1,4,5)P 3 . More recently, however, convincing claims have been made for an extracellular role of sphingosine 1-phosphate acting via a cell-surface receptor.
A more consistent picture is beginning to emerge, however, regarding the effects of ceramide on cell behaviour. Early studies with ceramide analogues suggested they were toxic to cells but it emerged subsequently that ceramide-induced toxicity bore all the hallmarks of programmed cell death, or apoptosis. Moreover, these effects were structurally specific, because close structural analogues with similar overall lipid character did not reproduce responses to ceramide itself. Such structural specificity implies the existence of protein receptors that bind and respond to ceramide. Although several candidates have been proposed, however, including protein kinases and phosphatases, there is still no convincing evidence that any of these proteins is a physiologically significant ceramide receptor.
If sphingomyelin and its metabolites are going to emerge as ubiquitous signalling molecules, some fundamental questions need to be resolved. Not least of these is the identities of sphingomyelinases which account for the synthesis of putative second messengers, such as ceramide, in response to appropriate stimuli. Also, sphingomyelin, like phosphatidylcholine, is likely to have both structural and signalling roles. We need to know how these roles are segregated and whether the pools of signalling sphingomyelin are intracellular or on the outer leaflet of the plasma membrane, where most of the sphingolipids are found. Nor do we yet have convincing candidates for ceramide receptors or know which signalling pathways that feed into the central apoptotic mechanisms they trigger.
These are not criticisms. In fact, they are remarkably similar questions to those that were being asked by researchers in the early 1980s who were convinced of the importance of inositol lipids in signalling; and look where addressing those questions has led us.
